Eli Lilly Launches "Brain Health Matters" Campaign with Julianne Moore to Promote Alzheimer's Disease Awareness

Eli Lilly and Company (NYSE:LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to encourage people to proactively manage their brain health and reduce the risk of dementia from conditions like Alzheimer’s disease.

The multi-year campaign builds on 35 years of Lilly’s research in brain health and aims to make proactive care a regular part of long-term wellness plans. The campaign is particularly focused on women, who account for ~two-thirds of Alzheimer’s disease diagnoses. To increase awareness, Lilly has partnered with acclaimed actress and advocate Julianne Moore in the US.

Moore portrayed a woman with early-onset Alzheimer’s in her film Still Alice and is encouraging individuals to have early conversations with their doctors about dementia risk, cognitive assessments, and lifelong brain health habits. According to a recent survey, ~four in five Americans would want to know if they have Alzheimer’s disease before symptoms become a daily issue. The campaign emphasizes that Alzheimer’s can begin as early as 20 years before symptoms appear due to the buildup of amyloid plaques in the brain.

Eli Lilly and Company (NYSE:LLY) discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.